Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

23andMe CEO addresses FDA setback

23andMe CEO Anne Wojcicki talks about the challenges her company faces in working with the FDA to get approval to market its DNA kits.

  • untitled
This video series features interviews with C-Level executives, high-level business leaders and policy makers covering strategy and current affairs from the perspective of the corner office.